STZ/HFD NAFLD mice receiving ALT-100 mAb treatment demonstrated significant disappearance of hepatocyte lipid accumulation and intrahepatic fat vacuole steatosis and near absence of hepatocyte ballooning and lobular inflammation (Figure 3C, fourth panel). This evidence concerns the gene GPT and steatosis.